The brilliance of discovery
Accelerating towards point-of-care
Sirigen’s technology drives simple, low cost near patient testing. Bright reporters provide highly sensitive and rapid results with either visual detection or low cost, low power hand held reader devices.
Superior results to inform better decisions
High Sensitivity Fluorescence™ provides greater sensitivity and permits analysis of more markers for the investigation and management of diseases like HIV and leukaemia, providing more meaningful information about disease earlier.
Here today, here tomorrow
Sirigen’s platform agnostic technology is compatible with instrumentation and assays from a wide variety of suppliers so it can be applied here and now. Our materials are also highly customisable and deliver numerous benefits for the next generation of diagnostics.
Powered by Sirigen™
Sirigen’s HSF™ technology is designed to boost the performance of existing assays be they molecular or immuno, Diagnostic or Research. Sirigen’s HSF™ materials are platform agnostic and are readily adopted using conventional protocols. HSF™ delivers technical and competitive edge.
The Sirigen brand represents the next generation of assays, the next generation of performance and the next generation of profitability for its adopters'.
What is HSF™?
HSF™ is High Sensitivity Fluorescence™. HSF™ is transforming Diagnostics and Research.
HSF™ delivers enhanced signals, lowering limits of detection and providing greater confidence in results. HSF™ delivers enhanced multiplexing and is applicable to a wide range of applications.
See how Sirigen polymers deliver superior performance and find out how our High Sensitivity Fluorescent™ materials can be tailored to your applications
The Brilliant Violet family of fluorescent dyes is now available, delivering PE levels of performance off the violet laser.
BD Acquires Sirigen Group Limited